Search
for

    Did you mean FDA Adverse Event Reporting System?
    Glossary FDA Adverse Event Reporting System

    database tracking drug and biologic safety issues post-marketing

    The FDA Adverse Event Reporting System (FAERS) is a database managed by the U.S. Food and Drug Administration that collects information on adverse events and medication errors reported by healthcare professionals, consumers, and manufacturers. This system helps the FDA monitor the safety of drugs and biologics after they are marketed, ensuring that any potential risks are identified and managed appropriately.

    Related Terms

    Research 10 of 1000+

    1. Drug related lipid metabolism abnormalities: a real-world pharmacovigilance exploratory analysis based on U.S. FDA adverse event reporting system (FAERS) Nutrición Hospitalaria · 2026
    2. Suicidal behaviors (suicidal ideation, suicide attempt and completed suicide) in patients treated with finasteride for hair loss: Results from the U.S. FDA Adverse Event Reporting System (FAERS) database Journal of The American Academy of Dermatology · 2018
    3. Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024 medRxiv (Cold Spring Harbor Laboratory) · 2024
    4. Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system Medicine · 2026
    5. Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database Skin Appendage Disorders · 2024
    6. A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System Pharmacology Research & Perspectives · 2025 · 2 citations
    7. Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system Frontiers in Pharmacology · 2024 · 30 citations
    8. A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system Scientific Reports · 2025 · 2 citations
    9. Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases Frontiers in Pharmacology · 2024 · 25 citations
    10. A pharmacovigilance study of drug‐reduced male semen quality based on the Food and Drug Administration adverse event reporting system database Andrology · 2024
    All research results →

    Learn 4 of 21

    1. Low Level Laser Therapy Red-light devices, such as caps, combs and helmets, used on the scalp
    2. Tofacitinib JAK inhibitor pill, an immune-system drug
    3. Pyrilutamide Experimental topical anti-androgen, also known as KX-826
    4. Exosomes Tiny cell-derived particles offered by clinics as an injectable treatment
    All learn results →

    Community

    — no results

    Try a deeper search in community →